These data suggest that aberrant CpG island methylation of the IGFBP3 promoter region is a late event in the genesis of pediatric liver tumors and might predict the evolution of HB to a highly aggressive, metastatic, and vascular-invasive phenotype with worse outcomes. This evidence concerns the gene IGFBP3 and hemoglobin measurement.